Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis

Arnold, Michael B.; Khanna, Dinesh; Denton, Christopher P.; van Laar, Jacob M.; Frech, Tracy M.; Anderson, Marina E.; Baron, Murray; Chung, Lorinda; Fierlbeck, Gerhard; Lakshminarayanan, Santhanam; Allanore, Yannick; Riemekasten, Gabriela; Steen, Virginia; Mueller-Ladner, Ulf; Spotswood, Helen; Burke, Laura; Siegel, Jeffrey; Jahreis, Angelika; Furst, Daniel E.; Pope, Janet E.

Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis

Autor(en):

Arnold, Michael B.; Khanna, Dinesh; Denton, Christopher P.; van Laar, Jacob M.; Frech, Tracy M.; Anderson, Marina E.; Baron, Murray; Chung, Lorinda; Fierlbeck, Gerhard; Lakshminarayanan, Santhanam; Allanore, Yannick; Riemekasten, Gabriela; Steen, Virginia; Mueller-Ladner, Ulf; Spotswood, Helen; Burke, Laura; Siegel, Jeffrey; Jahreis, Angelika; Furst, Daniel E.; Pope, Janet E.

Tübinger Autor(en):

Fierlbeck, Gerhard

Erschienen in:

Rheumatology (2018), Bd. 57, H. 1, S. 152-157

Verlagsangabe:

Oxford Univ Press

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1093/rheumatology/kex396

ISSN:

1462-0332